3D Bioprinting Market is Driven by High Demand of Tissues and Organs for Transplantation Across the Globe
The market is driven by factors, such as technological advancements and innovations, increasing compliance for drug discovery processes, and high demand for organ and tissue transplantation. In terms of technology, the 3D bioprinting market has been segmented into syringe based 3D bioprinting, pneumatic extrusion based 3D bioprinting, inkjet based 3D bioprinting, laser based 3D bioprinting and others. The syringe based 3D bioprinting was the most commonly used bioprinting technology; whereas, pneumatic extrusion based 3D bioprinting is expected to witness the fastest growth during the foreast period. 3D bioprinting has opened up new platforms in the drug discovery and development process. Many drugs are withdrawn or not approved by regulatory authority due to their toxicity to certain organ such as liver, which could not be predicted during the pre-clinical trial process. Tissues developed through 3D bioprinting such as liver tissue help to predict drug toxicity and improve...